Recombinant Human Carcinoembryonic Antigen (CEA)

Recombinant Human CEA, derived from the transfected human HEK293 cells

$369.00  
230-30015-100
+

Product Specifications

Size:
10 ug, 50 ug, or 100 ug
Format:
Lyophilized powder
Formulation:
Lyophilized from a 0.2 um filtered solution in PBS
Purification:
His-tag affinity purification by immobilized metal ion affinity chromatography (IMAC)
Concentration (lot specific):
Determined by BCA protein assay kit (Thermo Scientific)
Purity:
> 95%
Reconstitution:
Briefly spin the vial and bring the contents to the bottom prior to opening. It is recommended to reconstitute at 0.5 - 1.0 mg/mL with sterile deionized water or 1x PBS.
Endotoxin Level:
Not determined
Purity determined by:
SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Preservative:
None
Recommended Applications:
ELISA, EIA, protein-protein interaction studies, Western Blotting, Dot Blotting, Immunoprecipitation, Protein Array

Source

Gene Symbols:
  • CEACAM5
Species:
Human
Accession Number:
  • Q8N4D0
Expressed Region:
Lys35-Ala685
Protein Name & Synonyms:
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5, CEA, Meconium Antigen 100, CD66e, Carcinoembryonic Antigen, CD66e Antigen

Preparation

Expression System:
Human Embryonic Kidney 293 Cells
Tag:
His
Conjugation/Tag Notes:
N-terminal 6x histidine tag
Molecular Weight (kDa):
The recombinant human CEA has a calculated molecular mass of 71 kDa. Due to the abundant glycosylation, it migrates as approximately 125-150 kDa protein bands (confirmed by Western blotting) in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions.
SDS-PAGE Image
SDS-PAGE
Figure 1. Deglycosylation of purified recombinant proteins. Purified proteins were untreated (Lane 2) or treated with protein deglycosylation enzymes under native (Lane 3) or reducing (Lane 4) conditions. Deglycosylation treatment resulted in a mobility shift of the protein to produce one major band at the expected size, thus indicating that the untreated recombinant protein (Lane 2) was glycosylated.
Lane 1: Protein standard ladder (kDa).
Lane 2: Untreated protein under reducing conditions.
Lane 3: Treated protein with deglycosylation enzymes under native conditions.
Lane 4: Treated protein with deglycosylation enzymes under reducing conditions.
Lane 5: Deglycosylation mixture only without target proteins.

Stability & Storage

Shipping
Ice packs
Storage/Stability
Upon arrival, the lyophilized protein may be stored for 2 weeks at 4°C. For long term storage, it is recommended to store desiccated below -20 °C in a manual defrost freezer. Following reconstitution, the protein may be stored for 2 weeks under sterile conditions at -20 °C.  For long term storage, it is recommended to make appropriate aliquots and store at -80 °C. Avoid repeated freeze-thaw cycles.

Custom Labeling Request

We can custom label this protein with biotin or fluorescent dyes (choose from violet, blue, green or red). Request now.

No posts found

Write A Review
U.S. Non-U.S.

Usage

This product is furnished for LABORATORY RESEARCH USE ONLY.
Not for diagnostic or therapeutic use.

Recently Viewed Recently Viewed

Customers Also Bought Customers Also Bought